Physician profile
Duaa Jabari
NPI 1124374442
$9,544.29
in general payments reported to CMS, 2019-2025
8 companies · $90.58 in 2025
The $90.58 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.13 · 2022: $13.03 · 2023: $1,202 · 2024: $8,222 · 2025: $90.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,975 · Travel and Lodging: $1,922 · Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,975.00 |
| Travel and Lodging | $1,922.45 |
| Food and Beverage | $617.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sarepta Therapeutics, INC. | $8,222.13 | 2024 | |
| Janssen Research & Development, LLC | $1,138.52 | 2023 | |
| Life Molecular Imaging LTD | $90.58 | 2025 | Neuraceq |
| Hospira, INC. | $76.93 | 2022-2023 | |
| Apria Healthcare LLC | $16.13 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duaa Jabari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.